FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $637,000 | +422.1% | 10,885 | +427.1% | 0.14% | +264.9% |
| Q3 2021 | $122,000 | -85.6% | 2,065 | -78.9% | 0.04% | -84.8% |
| Q2 2021 | $850,000 | +51.8% | 9,792 | +44.2% | 0.24% | +28.4% |
| Q1 2021 | $560,000 | -16.3% | 6,792 | -7.6% | 0.19% | -12.0% |
| Q4 2020 | $669,000 | -46.6% | 7,352 | -76.5% | 0.22% | -43.2% |
| Q3 2020 | $1,252,000 | +51.4% | 31,317 | +30.0% | 0.38% | +61.7% |
| Q2 2020 | $827,000 | – | 24,092 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |